Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Fewer Infusions, Same Protection? Rethinking Ocrelizumab Dosing in Multiple Sclerosis
Genetics
Fewer Infusions, Same Protection? Rethinking Ocrelizumab Dosing in Multiple Sclerosis

25, Aug 2025

2
Fewer Infusions, Same Protection? Rethinking Ocrelizumab Dosing in Multiple Sclerosis
Genetics
Ocrelizumab Rewrites the T-Cell Script in Early Multiple Sclerosis

25, Aug 2025

3
B Cells in the Spotlight: How Ocrelizumab Is Changing the Story of Multiple Sclerosis
Genetics
B Cells in the Spotlight: How Ocrelizumab Is Changing the Story of Multiple Sclerosis

23, Aug 2025

4
A Genetic Brake on Multiple Sclerosis: How SLC9A9 Shapes Treatment Response
Genetics
A Genetic Brake on Multiple Sclerosis: How SLC9A9 Shapes Treatment Response

22, Aug 2025

5
Why Some MS Patients Bounce Back Too Fast: New Clues from African Ancestry Immune Responses
Genetics
Why Some MS Patients Bounce Back Too Fast: New Clues from African Ancestry Immune Responses

22, Aug 2025

Categories:
Genetics
Moving Beyond "One Drug Fits All" in Multiple Sclerosis: The Dawn of Personalized Medicine
Genetics
Moving Beyond "One Drug Fits All" in Multiple Sclerosis: The Dawn of Personalized Medicine

27, Apr 2025

Decoding MS Treatment Response: Could Our Genes Hold the Key to Better Outcomes with Glatiramer Acetate?
Genetics
Decoding MS Treatment Response: Could Our Genes Hold the Key to Better Outcomes with Glatiramer Acetate?

28, Apr 2025

Multiple Sclerosis Treatment Response and the Role of Genetic Variations
Genetics
Multiple Sclerosis Treatment Response and the Role of Genetic Variations

29, Apr 2025

Genetic Variations Influencing Glatiramer Acetate Response in Multiple Sclerosis: A Pharmacogenomic Perspective
Genetics
Genetic Variations Influencing Glatiramer Acetate Response in Multiple Sclerosis: A Pharmacogenomic Perspective

30, Apr 2025